Home | News | Events | Contact Us | English | 繁體中文 | 日本語
About Us Product & Service Facilities Quality & Compliance For Investors Career
Latest Events
Latest News
Product & Service
CPhI Japan, Osaka, Japan
Sep. 30- Oct. 2, 2020
CPhI Worldwide, Milano, Italy
Oct. 13-15, 2020
US Patent No.US10626110B2 entitled Polymorph of Pazopanib Hydrochloride and preparation process thereof was granted on April 21, 2020. 2020-05-12
Filed JP DMF of Alfacalcidol (#302MF10045, date of submission:Apr. 10, 2020) 2020-04-21
Filed CN DMF of Calcitriol (#Y20190021431, date of submission: Dec. 27, 2019) 2020-01-15
Filed CN DMF of Pazopanib Hydrochloride (#Y20190021452, date of submission: Dec. 26, 2019) 2020-01-14
Filed US DMF of Rucaparib Camsylate (#034419, date of submission: Dec. 26, 2019) 2019-12-27
Active Pharmaceutical Ingredients
Contract Development and Manufacturing Organization (CDMO)
Antibody Drug Conjugates (ADCs)
Injectable Manufacturing Services



 
Copyright ©2014 Formosa Laboratories, Inc. All Rights Reserved.
丙肝